Publication: PharmiWeb

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants

Idera Pharmaceuticals (Nasdaq: IDRA) today announced the pricing of an underwritten public offering by Idera Pharmaceuticals of (i) for a combined public offering price of $0.50 per share of common stock and related warrant 17500000 shares of common stock ... [Published PharmiWeb - 14 hours ago]

Entities: Idera Pharmaceuticals Inc, Common Shares, Exercise Price, warrants, Prospectus

First reported 14 hours ago - Updated 14 hours ago - 1 reports

DOTmed Business News’ Biomed Symposium

DOTmed Business News a leading health care magazine catering to industry professionals has published its May 2013 issue. This month’s cover story touts DOTmed Business News’ first ever biomed symposium. The conversation among leading experts offers some ... [Published PharmiWeb - 14 hours ago]

Entities: Biomed, Medical Equipment, Biome, Health Care

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Ferring to Present Safety Analysis for FIRMAGON® (degarelix) at the American Urological Association Annual Meeting

The following data will be presented at the annual meeting of the American Urological Association (AUA) in San Diego CA:Androgen deprivation therapy by a gonadotropin releasing hormone antagonist degarelix lowers the risk of cardiovascular events or death ... [Published PharmiWeb - 14 hours ago]

Entities: Ferring AB, American Urological Association, San Diego (California, United States), agonist

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Genemarkers Proud Sponsor of the Rare Disease Challenge

Genemarkers is proud to be a sponsor of the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries) and work with Lori Silveira at National Jewish Health on her research project. Genemarkers will be providing Genomics ... [Published PharmiWeb - 14 hours ago]

Entities: Genomics, Beryllium, Assay Depot Inc, Expression Analysis Inc, gene expression profiling

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Novella Clinical Expands West Coast Business Development Team

Novella Clinical a full service clinical research organization (CRO) today announced two new hires to supplement business development efforts on the west coast. Joining as Directors of Client Business Development are Carole Gabos and Jeremie Braun.Carole ... [Published PharmiWeb - 14 hours ago]

Entities: Business Development, Nick Dyer, Medical Devices

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Fluidigm Corp

Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing

Fluidigm (www.fluidigm.com) today announced an agreement to develop and supply a customized version of its high-throughput library prep system to the DKMS (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft mbH) Life Science Lab. The new system ... [Published PharmiWeb - 14 hours ago]

Entities: Fluidigm Corp, Blood Cancer, Donor

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Transgenomic to Hold First Quarter Financial Results Conference Call on May 8, 2013

Transgenomic Inc. (OTCBB: TBIO) today announced the following Webcast:What: Transgenomic Inc. First Quarter 2013 Financial Results and Business Update Conference Call When:Wednesday May 8 2013 @ 5:00 p.m. Eastern Where:http://www.transgenomic.com/cal ... [Published PharmiWeb - 14 hours ago]

Entities: Transgenomic Incorporated, Oncology, Cardiology

First reported 14 hours ago - Updated 14 hours ago - 1 reports

ArQule to Report First Quarter 2013 Financial Results on May 8, 2013

ArQule Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the first quarter of 2013 on Wednesday May 8 2013 at 7:00 a.m. Eastern Time. The Company will hold a conference call at 9:00 a.m. Eastern Time that day to discuss ... [Published PharmiWeb - 14 hours ago]

Entities: ArQule Inc, Kinase, Receptor, Tivantinib, Adenosine Triphosphate

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Study Demonstrates Significant Pain Reduction with DFINE STAR™ Tumor Ablation System in Spinal Metastases

DFINE Inc. the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies released study results highlighting the clinical benefits of advanced Targeted-Radiofrequency Ablation™ (t-RFA) therapy for ... [Published PharmiWeb - 14 hours ago]

Entities: DFine Inc, Metastases, Ablation, Tumor

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Medgenics Announces Results of 2013 Annual Meeting of Stockholders

Medgenics Inc. (NYSE MKT: MDGN and AIM: MEDU MEDG) (the “Company” or “Medgenics”)the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue today announces that all resolutions ... [Published PharmiWeb - 14 hours ago]

Entities: Medgenics Inc, Hemophilia, biopsy, Stocks, anemia

First reported 14 hours ago - Updated 14 hours ago - 1 reports

Rite Aid Returns to Entertainment Industry Foundation Revlon Run/Walk For Women as Platinum Sponsor

Rite Aid (NYSE: RAD) is proud to announce its second straight year of support for one of the country's premier women's cancer run/walks marking platinum sponsorship for both the New York and the Los Angeles events this May. Rite Aid is fielding teams ... [Published PharmiWeb - 14 hours ago]

Entities: Rite Aid Corporation, Revlon Inc, Entertainment Industry Foundation, Denise Austin

First reported 14 hours ago - Updated 14 hours ago - 1 reports

BioForward Testifies in Support of Assembly Bill 181 and Increasing Pool of Capital in Wisconsin

Today the Assembly Committee on Jobs Economy and Mining held a public hearing on Assembly Bill 181 legislation that would create a venture capital investment program in Wisconsin. Bryan Renk Executive Director of BioForward testified in support of AB ... [Published PharmiWeb - 14 hours ago]

Entities: BioForward, Life Science, Wisconsin Legislature, Marketplace

Quotes

"We are thrilled to be part of the Rare Disease Challenge and to have the opportunity to assist Lori Silveira” says Dr. Anna Langerveld president and CEO of Genemarkers. “We are proud that our team of experienced genomics scientists can assist in advancing this research.”"

Genemarkers Proud Sponsor of the Rare Disease Challenge [Published PharmiWeb - 14 hours ago]

...the Entertainment Industry Foundation at both the New York and Los Angeles EIF Revlon Run/Walk events this year" said fitness expert Denise Austin. "Though I’ll be leading the warm ups and motivating runners and walkers for me the true inspiration will come from the crowd filled with survivors of women’s cancers and their many supporters.”"

Rite Aid Returns to Entertainment Industry Foundation Revlon Run/Walk For Women as Platinum Sponsor [Published PharmiWeb - 14 hours ago]

Kruger goes onto point out. "There are many areas where emotional responses to content has an important role as part of a mobile device's user interface." About Steinkrug

Android App For Dementia Research and Therapy. [Published PharmiWeb - May 22 2013]

...as our strategic corporate objective to build a leading global specialty pharmaceutical company," said Paul Bisaro, President and CEO of Actavis. "The combination of Actavis and Warner Chilcott creates a strong specialty brand portfolio focused in therapeutic categories with strong growth potential, and is supported by a deep pipeline of development programs. The combination is commercially and financially compelling, and reshapes the specialty pharmaceutical universe by creating a powerful global competitor. It creates a company with an exceptionally strong balance sheet, coupled with a favorable tax structure to support future growth."

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmac ... [Published PharmiWeb - May 21 2013]

More Content

sort by: Date \| Relevance
Top Pharmaceutical Companies Bridge the Gap bet... [Published PharmiWeb - 14 hours ago]
Sanofi Q1 2013 - Interview with CFO Jérôme Cont... [Published PharmiWeb - 14 hours ago]
Idera Pharmaceuticals Announces Pricing of Publ... [Published PharmiWeb - 14 hours ago]
Beware of Prescriptions Not Matching Pill Bottl... [Published PharmiWeb - 14 hours ago]
Demand for BioCheck Suspicious Powder Screening... [Published PharmiWeb - 14 hours ago]
Anacor Pharmaceuticals Announces Closing of $23... [Published PharmiWeb - 14 hours ago]
PPD’s Reputation Ranked Best of all CROs in Cen... [Published PharmiWeb - 14 hours ago]
California health system Joins the Premier heal... [Published PharmiWeb - 14 hours ago]
BioForward Testifies in Support of Assembly Bil... [Published PharmiWeb - 14 hours ago]
Novella Clinical Expands West Coast Business De... [Published PharmiWeb - 14 hours ago]
Genemarkers Proud Sponsor of the Rare Disease C... [Published PharmiWeb - 14 hours ago]
Ferring to Present Safety Analysis for FIRMAGON... [Published PharmiWeb - 14 hours ago]
DOTmed Business News’ Biomed Symposium [Published PharmiWeb - 14 hours ago]
Fluidigm to Develop and Supply a Custom High-th... [Published PharmiWeb - 14 hours ago]
Transgenomic to Hold First Quarter Financial Re... [Published PharmiWeb - 14 hours ago]
Rite Aid Returns to Entertainment Industry Foun... [Published PharmiWeb - 14 hours ago]
Medgenics Announces Results of 2013 Annual Meet... [Published PharmiWeb - 14 hours ago]
Study Demonstrates Significant Pain Reduction w... [Published PharmiWeb - 14 hours ago]
ArQule to Report First Quarter 2013 Financial R... [Published PharmiWeb - 14 hours ago]
QuantuMDx and Genome Institute of Singapore ann... [Published PharmiWeb - May 23 2013]
ASTELLAS RECEIVES MARKETING AUTHORISATION FOR V... [Published PharmiWeb - May 23 2013]
GlaxoSmithKline awarded up to $200 million by U... [Published PharmiWeb - May 23 2013]
Android App For Dementia Research and Therapy. [Published PharmiWeb - May 22 2013]
Actavis to Acquire Warner Chilcott to Create Pr... [Published PharmiWeb - May 21 2013]
ClinTec International expands further in MENA r... [Published PharmiWeb - May 21 2013]
UKCPA accepts General Committee members followi... [Published PharmiWeb - May 20 2013]
UKCPA Clinical Pharmacy Research Grant winner a... [Published PharmiWeb - May 20 2013]
CML Drug Revenue in Japan to Grow, Despite Glob... [Published PharmiWeb - May 20 2013]
Sanofi Reports Positive Topline Results from Pi... [Published PharmiWeb - May 17 2013]
Merck Serono and Quintiles Announce Innovative ... [Published PharmiWeb - May 16 2013]